ASPER BIOGENE OÜ - 14265334 | ScoreStorybook | Print Summary Report
STORYBOOK OÜ Tähe 129b, Tartu, 50113 ESTONIA (+372)7446645 info@scorestorybook.ee ssb.ee
[mo_oauth_login]

ASPER BIOGENE OÜ

Summary report

Date of report 03.01.2025

ASPER BIOGENE OÜ
14265334 - Registered
Founded in 24.05.2017
Fixed capital 2,500 €

Former names

  • Mendel OÜ
VAT  
EE101984009 (start 30.06.2017)
start end
30.06.2017 -

Add ASPER BIOGENE OÜ data to your system

download JSON download CSV

Add ASPER BIOGENE OÜ data to your information system with one click or download a CSV file. The data is enriched with direct links to Storybook reports. See also the list of machine-readable data.

Don't have CRM? Read more

keywords

  • teadustegevus biotehnoloogias

ASPER BIOGENE OÜ

Scores and ratings

Reputation score

What is Reputation score?

Credit Score

Trustworthy 0.01

Loader

What is Credit Score?

Open the reports you want to print

Employees and salaries

ASPER BIOGENE OÜ

Number of employees and estimated average salaries
?

ASPER BIOGENE OÜ

Employee taxes and performance analysis
?
QuarterLabor taxes
paid		Number of employees
Turnover
Per Employee		Profit
per employee
2024 III........................
2024 II........................
2024 I........................
2023 IV........................
2023 III........................
2023 II........................
2023 I........................
2022 IV........................
2022 III........................
2022 II........................
2022 I........................
2021 IV........................
2021 III........................
2021 II........................
2021 I........................
2020 IV........................
2020 III........................
2020 II........................
2020 I........................
2019 IV........................
2019 III........................
2019 II........................
2019 I........................
2018 IV........................
2018 III........................
2018 II........................
2018 I........................
2017 IV........................
2017 III........................
2017 II........................

Deciders and beneficiaries

ASPER BIOGENE OÜ

Decision-makers
?

Former decision-makers

Hardi Tamm

Relations: 6
Turnover 2024: 1 183 558 €
Employees: 24
Hardi Tamm
★★★★

......

Related companies scores

Credit Score: Trustworthy

Reputation score: 4100

Date of birth: ......

Active relations 6

Research activities in biotechnologyAgricultural societiesBusiness adviceBusiness adviceDevelopment activities in nature and engineering
*

ASPER BIOGENE OÜ

Former decision-makers
?

Villem Aruoja

Relations: 4
Turnover 2024: 1 302 952 €
Employees: 5
Villem Aruoja
★★★★

......

Related companies scores

Credit Score: Trustworthy

Reputation score: 3610

Date of birth: ......

Active relations 4

Retail sale of medical goodsActivities of other professional organisationsActivities of housing associations

Annetriin Treier

Relations: 1
Turnover:
Employees:
Annetriin Treier
★★★★

......

Related companies scores

Credit Score: Trustworthy

Reputation score: 70

Date of birth: ......

Active relations 1

Activities of housing associations

Eneli Oitmaa

Relations: 1
Turnover:
Employees:
Eneli Oitmaa
★★★★

......

Related companies scores

Credit Score: Trustworthy

Reputation score: 360

Date of birth: ......

Active relations 1

Other retail

Toomas Peterson

Relations: 1
Turnover:
Employees:
Toomas Peterson
★★★★

......

Related companies scores

Credit Score: Trustworthy

Reputation score: 450

Date of birth: ......

Active relations 1

Leisure Interest Club

ASPER BIOGENE OÜ

Owners
?

Former owners

NameCredit ScorePaymentBeginningTypeHolding
0.05
..................
100%

Former owners

NameCredit ScorePaymentBeginningEnding
0.05
..................
0.04
..................

ASPER BIOGENE OÜ

Subsidiaries and associates
?

Former subsidiaries and associates

Former subsidiaries and associates

NameCredit ScorePaymentBeginningEnding
0.01
..................
0.01
..................
0.05
..................

Beneficiaries

Volumes and values ​​of beneficiaries' assets

Finances and assets

ASPER BIOGENE OÜ

Goodwill

ASPER BIOGENE OÜ

Taxes paid and estimated average salaries

ASPER BIOGENE OÜ

Quarterly indicators
QuarterTurnoverTaxed turnoverLabour productivityLabour productivityEmployeesNational taxesLabor taxes
2024 III* ............* ..............................
2024 II* ............* ..............................
2024 I* ............* ..............................
2023 IV* ............* ..............................
2023 III* ............* ..............................
2023 II* ............* ..............................
2023 I* ............* ..............................
2022 IV* ............* ..............................
2022 III* ............* ..............................
2022 II* ............* ..............................
2022 I* ............* ..............................
2021 IV* ............* ..............................
2021 III* ............* ..............................
2021 II* ............* ..............................
2021 I* ............* ..............................
2020 IV* ............* ..............................
2020 III* ............* ..............................
2020 II* ............* ..............................
2020 I* ............* ..............................
2019 IV* ............* ..............................
2019 III* ............* ..............................
2019 II* ............* ..............................
2019 I* ............* ..............................
2018 IV* ............* ..............................
2018 III* ............* ..............................
2018 II* ............* ..............................
2018 I* ............* ..............................
2017 IV* ............* ..............................
2017 III* ............* ..............................
2017 II* ............* ..............................

ASPER BIOGENE OÜ

Sales revenue by business area

ASPER BIOGENE OÜ

Sales revenue by country

ASPER BIOGENE OÜ

Financial indicators and prognosis

ASPER BIOGENE OÜ

Financial raiting: "VERY GOOD" (2024 prognosis)
2024 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good

ASPER BIOGENE OÜ

Annual reports
Year Period Submitted Report PDF
2023 01.01.2023–31.12.2023 27.06.2024 ......
2022 01.01.2022–31.12.2022 26.06.2023 ......
2021 01.01.2021–31.12.2021 30.06.2022 ......
2020 01.01.2020–31.12.2020 25.06.2021 ......
2019 01.01.2019–31.12.2019 02.07.2020 ......
2018 01.01.2018–31.12.2018 29.06.2019 ......
2017 01.01.2017–31.12.2017 30.06.2018 ......

Liabilities and debts

ASPER BIOGENE OÜ

Credit score history and prognosis
Publish claims
Recommended credit limit

... €

Recommended payment term

......

Business risk classes:

Trustworthy Neutral
Borderline Problematic Risky

ASPER BIOGENE OÜ

Reports and assets-liabilities overview 03.01.2025
?
Annual reports: ......
Annual reports: ......
Tax declarations:......
Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €

ASPER BIOGENE OÜ

Claims history
?
1 month
6 months
Year
5 years
MAX
Debt claims as of ......
Tax debt ...... €
Debt claims ...... €

Total debt claims: ...... €

Latest events
...... ......

ASPER BIOGENE OÜ

Income (turnover) and expenditure (taxes paid)
?
QuarterTurnoverTaxed turnoverNational taxes paidLabor taxes paidNumber of employees
2024 III* ...... €...... €...... €...... €......
2024 II* ...... €...... €...... €...... €......
2024 I* ...... €...... €...... €...... €......
2023 IV* ...... €...... €...... €...... €......
2023 III* ...... €...... €...... €...... €......
2023 II* ...... €...... €...... €...... €......
2023 I* ...... €...... €...... €...... €......
2022 IV* ...... €...... €...... €...... €......
2022 III* ...... €...... €...... €...... €......
2022 II* ...... €...... €...... €...... €......
2022 I* ...... €...... €...... €...... €......
2021 IV* ...... €...... €...... €...... €......
2021 III* ...... €...... €...... €...... €......
2021 II* ...... €...... €...... €...... €......
2021 I* ...... €...... €...... €...... €......
2020 IV* ...... €...... €...... €...... €......
2020 III* ...... €...... €...... €...... €......
2020 II* ...... €...... €...... €...... €......
2020 I* ...... €...... €...... €...... €......
2019 IV* ...... €...... €...... €...... €......
2019 III* ...... €...... €...... €...... €......
2019 II* ...... €...... €...... €...... €......
2019 I* ...... €...... €...... €...... €......
2018 IV* ...... €...... €...... €...... €......
2018 III* ...... €...... €...... €...... €......
2018 II* ...... €...... €...... €...... €......
2018 I* ...... €...... €...... €...... €......
2017 IV* ...... €...... €...... €...... €......
2017 III* ...... €...... €...... €...... €......
2017 II* ...... €...... €...... €...... €......

ASPER BIOGENE OÜ

Bailiff's enforcement proceedings as of 03.01.2025
?

Bailiff's enforcement proceedings MISSING

ASPER BIOGENE OÜ

Regulations of the Payment Order Department as of 03.01.2025
?

Regulations of the Payment Order Department MISSING

ASPER BIOGENE OÜ

Court orders in the register as of 03.01.2025
?
Logo

Puuduste kõrvaldamise määrus

30.12.2019

Regulation number: Ä 50057920 / M2

Regulation status has entered into force: 02.01.2020

Date of enforcement of order or additional period: 30.12.2019

Regulation status: Puudused kõrvaldatud

ASPER BIOGENE OÜ

Decisions of the Consumer Disputes Committee as of 03.01.2025
?

Consumer disputes MISSING

ASPER BIOGENE OÜ

Court hearings as of 03.01.2025
?

Court hearings MISSING

ASPER BIOGENE OÜ

Rulings as of 03.01.2025
?

Court settlemets MISSING

ASPER BIOGENE OÜ

Notices and announcements as of 03.01.2025
?
Logo

Notice of issuing an activity licence for handling of infectious material

22.09.2017
Nakkusohtliku materjali käitlemise tegevusloa väljaandmise teade
Avaldamise algus: 22.09.2017
Avaldamise lõpp: tähtajatu
Terviseamet avaldab teadaande nakkushaiguste ennetamise ja tõrje seaduse (NETS) § 34 lõike 3 alusel.

Terviseamet teatab, et taotlejale Asper Biogene OÜ laborile (registrikood: 14265334) asukohaga Vaksali 17A, Tartu on 18.09.2017 antud nakkusohtliku materjali käitlemise tegevusluba nr 81.

Tegevusloaga anti luba käidelda 2. ohurühma kuuluvaid patogeene.

Loaga saab tutvuda tööpäevadel Terviseametis, Hiiu 42, Tallinn 11619.
Loa kehtivus on 5 aastat (NETS § 37).
Ärinimed
Asper Biogene OÜ laborile, kehtetud ärinimed: Mendel OÜ.
Terviseamet
Paldiski mnt 81, Tallinn, 10617
Telefon: 7943500
E-post: kesk@terviseamet.ee
Teadaande avaldaja kontaktandmed:
peadirektori asetäitja (järelevalve) Mihhail Muzõtšin
Telefon: 6943 703
E-post: mihhail.muzotsin@terviseamet.ee
Teadaande number 1195067

Marketing

Business network

ASPER BIOGENE OÜ

 Business network
CREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired

Beneficiaries network

ASPER BIOGENE OÜ

 Networks - Beneficiaries
The network is visible with reduced links
Expand threads if desired

Monitoring events

Filter

Dropdown

Year

Dropdown

Type

Neutral

Positive

Negative

No monitoring events found.

Failed to load monitoring events.